Kathryn G. Guggenheim, Ph.D.
Affiliations: | 2012 | Chemistry | University of California, Davis, Davis, CA |
Area:
Combinatorial chemistry, heterocyclic chemistry, understanding reaction mechanisms, solid phase organic synthesis, polymer chemistry, organic synthesis, reaction methodology, and structure elucidationGoogle:
"Kathryn Guggenheim"Mean distance: 8.92 | S | N | B | C | P |
Parents
Sign in to add mentor| Mark Joseph Kurth | grad student | 2012 | UC Davis | |
| (Spiro-Fused Pyrazolidoylisoxazolines, Quinazolinotriazolobenzodiazepines, and Staged Inhibitors: Methodology Development and Biological Application.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Shuai Z, Wang J, Badamagunta M, et al. (2017) The Fingerprint of Antimitochondrial Antibodies and the Etiology of Primary Biliary Cholangitis. Hepatology (Baltimore, Md.) |
| Guggenheim KG, Toru H, Kurth MJ. (2012) One-pot, two-step cascade synthesis of quinazolinotriazolobenzodiazepines. Organic Letters. 14: 3732-5 |
| Naiyanetr P, Butler JD, Meng L, et al. (2011) Electrophile-modified lipoic derivatives of PDC-E2 elicits anti-mitochondrial antibody reactivity. Journal of Autoimmunity. 37: 209-16 |
| Guggenheim KG, Butler JD, Painter PP, et al. (2011) Synthesis of spiro-fused pyrazolidoylisoxazolines. The Journal of Organic Chemistry. 76: 5803-12 |
| Ziebart KT, Dixon SM, Avila B, et al. (2010) Targeting multiple chorismate-utilizing enzymes with a single inhibitor: validation of a three-stage design. Journal of Medicinal Chemistry. 53: 3718-29 |